AWG
CYTK icon

Alpha Wave Global’s Cytokinetics CYTK Stock Holding History

Alpha Wave Global’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,785,000
Closed -$8.53M – 22
2014
Q2 		$8.53M Buy
+1,785,000
New +$10.9M 0.48% 28

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha Wave Global's CYTK Position: Q3 2014 in Review

Alpha Wave Global sold out of Cytokinetics (CYTK) in Q3 2014, closing a stake of 1,785,000 shares — an estimated $8.53M sold.

Alpha Wave Global first reported a position in CYTK in Q2 2014 and held it in 1 quarter. The position peaked at $8.53M in Q2 2014. 85 funds tracked by Wall St. Rank hold CYTK as of Q3 2014.

  • Alpha Wave Global reported no remaining Cytokinetics position as of Q3 2014 after selling out during the quarter.
  • Alpha Wave Global sold 1,785,000 Cytokinetics shares in Q3 2014, an estimated $8.53M.
  • Alpha Wave Global first reported a position in Cytokinetics in Q2 2014 and held it in 1 quarter.
  • Alpha Wave Global's Cytokinetics position peaked at $8.53M in Q2 2014.
  • 85 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2014.

Based on Alpha Wave Global's 13F filing for Q3 2014, filed 14 Nov 2014.